Cascadia Capital, an investment bank serving middle-market clients globally, today announced that its client The F.L. Emmert Company (“Emmert” or the “Company”), a leading manufacturer and marketer of advanced nutritional solutions for the pet and livestock industries, has been acquired by Wilbur-Ellis Nutrition part of the Wilbur-Ellis companies, an international marketer, distributor and manufacturer of agricultural products, animal nutrients, specialty chemicals and ingredients. Cascadia served as the exclusive financial advisor to Emmert.
“Emmert represents the life work of our family across multiple generations,” said Carol Rod, Owner of Emmert. “While the sale of our business closes one chapter, it is also a new beginning. The idea that our science and innovation may reach a much broader audience brings our family satisfaction. We are grateful to be putting our family legacy in the hands of another highly regarded family business. Cascadia was an excellent partner in this journey.”
Emmert is a 140-year-old, family-owned company with manufacturing operations in Cincinnati, Ohio, and 35-plus employees. The Company has a proven track record in animal nutrition, delivering the right balance of brewer’s yeast, protein, vitamins, and essential amino acids to support companion animal and livestock health. As a value-added processor in the expanding U.S. and global markets, Emmert is well-known as an innovator with strong research and development capability.
“This transaction builds on our established track record of representing companies in both the ingredient sector and the companion animal and livestock end markets,” said Bryan Jaffe, Cascadia Capital Managing Director. “We are very appreciative of the trust the Rod family placed in us to find a home for their family legacy.”
“Increasingly, ingredient companies are playing a valuable role in addressing challenges and unlocking opportunities in the companion and production animal markets,” said Scott Porter, Cascadia Capital Managing Director. “Emmert’s specialized process for drying and enhancing brewer’s yeast to deliver vitality benefits and replace more costly protein content was well rewarded in this transaction. The Company brings to Wilbur-Ellis Nutrition an enviable client roster and product set that will serve a global audience in the future.”
The sale of Emmert represents another successful transaction in agribusiness and companion animal sector for Cascadia Capital and a continued demonstration of our experience in the consumables category.
For more information about this transaction, please contact the Cascadia Capital deal team:
Or other senior members of the Cascadia Food, Beverage & Agribusiness practice:
Chairman & CEO